Individuals with SARS-CoV-2 infection and uncontrolled glycemia have higher concentrations of inflammatory biomarkers than patients without diabetes, including C-reactive protein (CRP), ferritin, and IL-6 (17). The gene discussed is CRP; the disease is diabetes mellitus.